Related Experiment Video
Updated: Jul 2, 2026

10:02
Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
Three new lanostane-type triterpenoids with cytotoxic activity from the Ganoderma leucocontextum
Rong Fu1, Xiaohong Li1, Yonggang Kang2
1College of Bioengineering and Biotechnology, Tianshui Normal University, Tianshui, China.
Natural Product Research
|July 1, 2026
Summary
Three new lanostane triterpenoids were isolated from the Tibetan mushroom Ganoderma leucocontextum. These compounds show potential as anti-hepatocellular carcinoma leads due to moderate cytotoxicity against HepG2 cells.
Area of Science:
- Natural Product Chemistry
- Medicinal Mushroom Research
- Triterpenoid Synthesis
Background:
- Ganoderma leucocontextum, a Tibetan medicinal mushroom, is a source of bioactive compounds.
- Triterpenoids are a class of natural products with diverse biological activities.
- Lanostane-type triterpenoids are known for their complex structures and therapeutic potential.
Purpose of the Study:
- To isolate and characterize new lanostane-type triterpenoids from Ganoderma leucocontextum.
- To investigate the cytotoxic effects of these novel compounds against cancer cell lines.
- To explore the potential of these compounds as leads for anti-hepatocellular carcinoma drug development.
Main Methods:
- Extraction of bioactive metabolites from Ganoderma leucocontextum using ethanol.
- Purification of compounds using repeated column chromatography and High-Performance Liquid Chromatography (HPLC).
- Structure elucidation through High-Resolution Time-of-Flight Mass Spectrometry (HRTOFMS) and Nuclear Magnetic Resonance (NMR) spectroscopy.
Main Results:
- Isolation of three new lanostane-type triterpenoids, named ganoleucocontins S-U (1-3).
- Detailed structural determination, including planar skeletons and stereochemical configurations, was achieved.
- Cytotoxicity assays revealed moderate inhibitory effects on the HepG2 cell line (liver cancer cells), with IC50 values ranging from 19.86 to 35.24 μM.
Conclusions:
- The study successfully identified novel triterpenoids, expanding the known structural diversity of Ganoderma metabolites.
- Ganoleucocontins S-U exhibit promising cytotoxic activity against hepatocellular carcinoma cells.
- These findings suggest that Ganoderma leucocontextum triterpenoids are potential candidates for further development as anti-cancer therapeutics.
Related Concept Videos
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...